PET Imaging in Glioma The Neuro-Oncologist's Expectations

被引:2
作者
Hottinger, Andreas F. [1 ]
Levivier, Marc [1 ]
Negretti, Laura [2 ]
Homicsko, Krisztian [3 ]
Stupp, Roger [1 ]
机构
[1] Univ Lausanne Hosp, Dept Clin Neurosciences, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne Hosp, Dept Radiat Therapy, CH-1011 Lausanne, Switzerland
[3] Univ Lausanne Hosp, Dept Med Oncol, CH-1011 Lausanne, Switzerland
关键词
PET; Brain tumor; Glioma; Neuro-oncology; Imaging;
D O I
10.1016/j.cpet.2012.09.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PET-imaging is a useful tool for management of certain glioma patients. The variable availability of adequate tracers, their short half-life, but also administrative obstacles and financial constraints are hampering the prospective evaluation of PET. Its impact in tumor localization and accurate diagnosis, in treatment response evaluation and ultimately patient outcome needs to be demonstrated. Systematic algorithms for optimal and economical use are needed. We summarize the limitations of the usual imaging techniques, and of the added value of PET-imaging in specific clinical situations. We call for prospective studies and registries rather than the current largely resource-driven use of this valuable technique.
引用
收藏
页码:117 / +
页数:13
相关论文
共 94 条
[1]  
ALAVI JB, 1988, CANCER, V62, P1074, DOI 10.1002/1097-0142(19880915)62:6<1074::AID-CNCR2820620609>3.0.CO
[2]  
2-H
[3]   Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities [J].
Alexiou, George A. ;
Tsiouris, Spyridon ;
Kyritsis, Athanasios P. ;
Voulgaris, Spyridon ;
Argyropoulou, Maria I. ;
Fotopoulos, Andreas D. .
JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (01) :1-11
[4]  
Barker FG, 1997, CANCER, V79, P115, DOI 10.1002/(SICI)1097-0142(19970101)79:1<115::AID-CNCR17>3.3.CO
[5]  
2-#
[6]  
Barker FG, 1997, CANCER, V80, P936
[7]   Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation [J].
Barwick, Tara ;
Bencherif, Badreddine ;
Mountz, James M. ;
Avril, Norbert .
NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (12) :908-917
[8]   Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine [J].
Becherer, A ;
Karanikas, G ;
Szabó, M ;
Zettinig, G ;
Asenbaum, S ;
Marosi, C ;
Henk, C ;
Wunderbaldinger, P ;
Czech, T ;
Wadsak, W ;
Kletter, K .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) :1561-1567
[9]   Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis [J].
Benoit, Amandine ;
Ducray, Francois ;
Cartalat-Carel, Stephanie ;
Psimaras, Dimitri ;
Ricard, Damien ;
Honnorat, Jerome .
JOURNAL OF NEUROLOGY, 2011, 258 (02) :328-329
[10]   MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients [J].
Brandes, Alba A. ;
Franceschi, Enrico ;
Tosoni, Alicia ;
Blatt, Valeria ;
Pession, Annalisa ;
Tallini, Giovanni ;
Bertorelle, Roberta ;
Bartolini, Stefania ;
Calbucci, Fabio ;
Andreoli, Alvaro ;
Frezza, Giampiero ;
Leonardi, Marco ;
Spagnolli, Federica ;
Ermani, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) :2192-2197